See references. The treatment of neuroblastoma with targeted antibody therapy appears to be available on various research protocols underway at the memorial sloan kettering cancer center in new york. Local physicians may be able to enrole a kid on a study by establishing a relationship with the center. For additional info: see: www. Mskec. Org ; for parent info see: www. Cncfhope. Org.
No. Neuroblastoma is not an infectious disease and therefore does not respond to antibiotics.
Sometimes. Some types of high risk neuroblastomas do qualify for treatment with certain kinds of antibody therapy. However, due to the complicated nature of this cancer treatment is very case-specific and not all neuroblastoma cases will be approached with this treatment modality.
No. Neuroblastoma is treated with a combination of surgery, radiation and chemotherapy.
High risk, after BMT. The monoclonal antibody therapy s designed to be given to patients who have 1) high risk disease (stage IV and some stage iii), 2) great response to chemo/surgery/radiation, 3) have recently had high dose chemo and have received stem cell rescue (aka bone marrow transplant). The treatment is intended to treat only microscopic disease. It can also be very toxic.